Alterations in the serum levels of soluble L, P and E-selectin 20 years after sulfur mustard exposure: Sardasht-Iran Cohort Study

International Immunopharmacology

Volumn 9, Issue 13-14, 2009, Pages 1477-1481

  Yaraee, Roya ^a   Ghazanfari, Tooba ^a   Faghihzadeh, Soghrat ^b   Mostafaie, Ali ^c   Soroush, Mohammad R ^d   Inai, Kouki ^e   Foroutan, Abbas ^f   Shams, Jalaleddin ^a   Naghizadeh, Mohammad M ^a,g   Hassan, Zuhair M ^b  

^a SHAHED UNIVERSITY   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d JANBAZAN MEDICAL AND ENGINEERING RESEARCH CENTER JMERC   (Iran)

^e HIROSHIMA UNIVERSITY   (Japan)

^f SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g FASA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adhesion molecules; Inflammatory markers; Iran; Mustard gas; Soluble E selectin; Soluble L selectin; Soluble P selectin

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; L SELECTIN; MUSTARD GAS; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; HUMAN; INFLAMMATION; IRAN; LEUKOCYTE COUNT; LONG TERM EXPOSURE; LYMPHOCYTE; MAJOR CLINICAL STUDY; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT;

CHEMICAL WARFARE AGENTS; COHORT STUDIES; HUMANS; INFLAMMATION MEDIATORS; IRAN; LUNG DISEASES; MUSTARD GAS; RESPIRATORY FUNCTION TESTS; SELECTINS; TIME FACTORS;

EID: 70350567852     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.08.024     Document Type: Article

References (42)

1. Ley K. The role of selectins in inflammation and disease. Trends Mol Med 9 6 (Jun 2003) 263-268
2. Steeber D.A., Subramanian H., Grailer J.J., Conway R.M., and Storey T.J. L-selectin-mediated leukocyte adhesion and migration. In: Ley K. (Ed). Adhesion molecules: function and inhibition (2007), Birkhäuser Verlag Basel, Switzerland
3. Khan A.I., Landis R.C., and Malhotra R. L-selectin ligands in lymphoid tissues and models of inflammation. Inflammation 27 5 (2003) 265-280
4. Bullard D.C. P- and E-selectin. In: Ley K. (Ed). Adhesion molecules: function and inhibition (2007), Birkhäuser Verlag Basel, Switzerland
5. McEver R.P. P-selectin glycoprotein ligand-1 (PSGL-1). In: Ley K. (Ed). Adhesion molecules: function and inhibition (2007), Birkhäuser Verlag Basel, Switzerland
6. Kappelmayer J., Nagy Jr. B., Miszti-Blasius K., Hevessy Z., and Setiadi H. The emerging value of P-selectin as a disease marker. Clin Chem Lab Med 42 5 (2004) 475-486
7. Toker E., Kazokoǧlu H., and Sahin S. Cell adhesion molecules in subretinal fluid: soluble forms of VCAM-1 (vascular cell adhesion molecule-1) and L-selectin. Int Ophthalmol 22 (1999) 71-76
8. Ulich T.R., Howard S.C., Remick D.G., Yi E.S., Collins T., Guo K., et al. Intratracheal administration of endotoxin and cytokines, VIII: LPS induces E-selectin expression: anti-E-selectin and soluble E-selectin inhibit acute inflammation. Inflammation 18 (1994) 389-398
9. Asaduzzaman M., Rahman M., Jeppsson B., and Thorlacius H. P-selectin glycoprotein-ligand-1 regulates pulmonary recruitment of neutrophils in a platelet-independent manner in abdominal sepsis. Br J Pharmacol 156 2 (2009) 307-315
10. Hayashi S., Abe K., Matsuoka H., Goya S., Morishita H., Mori M., et al. Increased level of soluble E-selectin in the serum from patients with idiopathic pulmonary fibrosis. Inflammation 28 1 (2004) 1-5
11. Takeuchi F., Benbenisty K.M., and Streilein R.D. Cutaneous endothelial cell activation in normal skin of patients with dermatitis herpetiformis associated with increased serum levels of IL-8, sE-Selectin, and TNF-alpha.Hall RP 3rd. J Invest Dermatol 126 6 (2006) 1331-1337
12. Kneuer C., Ehrhardt C., Radomski M.W., and Bakowsky U. Selectins-potential pharmacological targets?. Drug Discov Today 11 21-22 (2006) 1034-1040
13. Rychly J., and Nebe B. Therapeutic strategies in autoimmune diseases by interfering with leukocyte endothelium interaction. Curr Pharm Des 12 29 (2006) 3799-3806
14. Barthel S.R., Gavino J.D., Descheny L., and Dimitroff C.J. Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Ther Targets 11 11 (2007) 1473-1491
15. Romano S.J. Selectin antagonists: therapeutic potential in asthma and COPD. Treat Respir Med 4 2 (2005) 85-94
16. Khateri S., Ghanei M., Keshavarz S., Soroush M., and Haines D. Incidence of lung, eye, and skin lesions as late complications in 34, 000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 45 11 (2003) 1136-1143
17. Emad A., and Rezaian G.R. Immunoglobulins and cellular constituents of the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. Chest 115 5 (1999) 1346-1351
18. Emad A., and Emad Y. Increased granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) levels in BAL fluid from patients with sulfur mustard gas-induced pulmonary fibrosis. J Aerosol Med 20 3 (2007) 352-360
19. Emad A., and Emad Y. Increased in CD8 T lymphocytes in the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. Respir Med 101 4 (2007) 786-792
20. Balali-Mood M., and Hefazi M. The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam Clin Pharmacol 19 3 (2005) 297-315
21. Ghazanfari T., Faghihzadeh S., Araghizadeh H., Soroush M.R., Yaraee R., Hassan Z.M., et al. Sardasht-Iran Cohort Study of chemical warfare victims: design and methods. Arch Iran Med 12 1 (2009) 5-14
22. United Nations Security Council. Report of the mission dispatched by the Secretary General to investigate allegations of the use of chemical weapons in the conflict between the Islamic Republic of Iran and Iraq. Jun. 29, 1987 (1987), United Nations, New York, USA Report No.: S/18953
23. Report of the mission dispatched by the Secretary General to investigate allegations of the use of chemical weapons in the conflict between the Islamic Republic of Iran and Iraq. Jun.30, 1987. New York, USA, United Nations: United Nations Security Council; 1987 Jul 30. Report No.: S/19006.
24. Moaiedmohseni S., Ghazanfari T., Araghizadeh H., Soroush M.R., Yaraee R., Hassan Z.M., et al. Long-term health status 20 years after sulfur mustard exposure. Toxin Rev 28 1 (2009) 3-7
25. Shams J., Ghazanfari T., Yaraee R., Vaez Mahdavi M.R., Soroush M.R., Hassan Z.M., et al. Long-term hematological consequences of sulfur mustard on civilians of Sardasht 20 years after exposure. Toxin Rev 28 1 (2009) 39-43
26. Ehrhardta C., Kneuerb C., and Bakowsky U. Selectins-an emerging target for drug delivery. Adv Drug Deliv Rev 56 (2004) 527-549
27. Barkhausen T., Krettek C., and van Griensven M. L-selectin: adhesion, signalling and its importance in pathologic posttraumatic endotoxemia and non-septic inflammation. Exp Toxicol Pathol 57 1 (2005) 39-52
28. Yaraee R., Ghazanfari T., Ebtekar M., Ardestani S., and Rezaee A. Alterations in serum levels of inflammatory cytokines (TNF, IL-1 alpha, IL-1 beta and IL-1Ra) 20 years after sulfur mustard exposure: Sardsht-Iran Cohort Study. Int J Immunol 9 (2009) 1466-1470 (this issue)
29. Ballabh P., Kumari J., Krauss A.N., Shin J.J., Jain A., Auld P.A.M., et al. Soluble E-selectin, soluble L-selectin, soluble ICAM-1, dexamethasone, bronchopulmonary dysplasia. Pediatrics 111 (2003) 461-468
30. Stocker C.J., Sugars K.L., Harari O.A., Clive Landis R., Morley B.J., and Haskard D.O. TNF-a, IL-4, and IFN-g regulate differential expression of Pand E-selectin expression by porcine aortic endothelial cells. J Immunol 164 (2000) 3309-3315
31. Dietmar V., and Blanks J.E. Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev 79 (1999) 181-213
32. Ferroni P., Martini F., Riondino S., La Farina F., Magnapera A., Ciatti F., et al. Soluble P-selectin as a marker of in vivo platelet activation. Clin Chim Acta 399 1-2 (2009) 88-91
33. Tietz W., Allemand Y., Borges E., von Laer D., Hallmann R., Vestweber D., et al. CD4 T cells migrate into inflamed skin only if they express ligands for E- and P-selectin. J Immunol 161 (1998) 963-970
34. Newman W., Beall L.D., Carson C.W., Hunder G.G., Graben N., Randhawa Z.I., et al. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 150 2 (1993) 644-654
35. Haraldsen G., Kvale D., Lien B., Farstad I.N., and Brandtzaeg P. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J Immunol 156 7 (1996) 2558-2565
36. Kumar P., Amin M.A., Harlow L.A., Polverini P.J., and Koch A.E. Src and phosphatidylinositol 3-kinase mediate soluble E-selectin-induced angiogenesis. Blood 101 (2003) 3960-3968
37. Oh I.Y., Yoon C.H., Hur J., Kim J.H., Kim T.Y., Lee C.S., et al. Involvement of E-selectin in recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle. Blood 110 (2007) 3891-3899
38. Ghanei M. Delayed haematological complications of mustard gas. J Appl Toxicol 24 6 (2004) 493-495
39. Ghazanfari Z., Ghazanfari T., Kermani-Jalilvand A., Vaez-Mahdavi M.R., Foroutan A., Araghizadeh H., et al. Association of physical activity and IL-10 levels 20 years after sulfur mustard exposure: Sardasht-Iran Cohort Study. Int Immuno 9 (2009) 1504-1508 (this issue)
40. Vora M., Romero L.I., and Karasek M.A. Interleukin-l0 induces E-selectin on small and large blood vessel endothelial cells. J Exp Med 184 (1996) 821-829
41. Chu W., Presky D.H., Swerlick R.A., and Burns D.K. Alternatively processed human E-selectin transcripts linked to chronic expression of E-selectin in vivo. J Immunol 153 9 (1994) 4179-4189
42. Bloom B.J., Nelson S.M., Eisenberg D., and Alario A.J. Soluble intercellular adhesion molecule-1 and E-selectin as markers of disease activity and endothelial activation in juvenile idiopathic arthritis. J Rheumatol 32 (2005) 366-372